Study to Assess Immunegnicity & Safety of Pentavalent Meningococcal Vaccine (NmCV-5)

计划入组 1,800 人 · 首次发布于 2019 年 5 月 28 日

Study to Assess Immunegnicity & Safety of Pentavalent Meningococcal Vaccine (NmCV-5)

计划入组 1,800 人

Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents

计划入组 1,215 人 · 首次发布于 2023 年 11 月 13 日

Pentavalent meningococcal conjugate vaccine(PATH)

Pentavalent Meningococcal ABCYW vaccine(Sanofi Pasteur)

Pentavalent meningococcal conjugate vaccine (PATH/ Serum Institute of India)

AIM VACCINE

China

Hualan Biological Vaccine Inc.

China

Finlay Vaccine Institute

Pentavalent Meningococcal Vaccine Demonstrates Robust Immunogenicity and Safety in Phase 3 Trial

CDC Advisory Panel Recommends Expanded RSV Vaccination for Adults 50-59 With High-Risk Conditions

Novel Therapies and Vaccines Poised to Reshape Community Pharmacy in 2025